13 completed, 8 unknown, 1 terminated, 1 withdrawn. 23 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 23 | Completed 13, Unknown 8, Terminated 1, Withdrawn 1 |
Follow Lucentis: new trials by email Literature Review of Lucentis trials Research Report on Lucentis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery Ranibizumab - Wet Macular Degeneration, Cataract Extraction | Not applicable | Unknown | Ophthalmica Eye Institute | 16 | 2018-01-01 | 2019-05-09 |
| Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab intravitreal ranibizumab - Infant, Premature, Diseases | Not applicable | Completed | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 17 | 2017-05-01 | 2018-10-12 |
| Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO Ranibizumab combined macular laser, Ranibizumab - Branch Retinal Vein Occlusion, Ranibizumab | Not applicable | Completed | Beijing Hospital | 80 | 2017-02-14 | 2022-12-28 |
| Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy ranibizumab, sham, pars plana vitrectomy - Proliferative Diabetic Retinopathy | Not applicable | Completed | Sun Yat-sen University | 90 | 2014-07-01 | 2017-10-16 |
| A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy. Ranibizumab, Aflibercept - Age Related Macular Degeneration | Not applicable | Completed | King's College Hospital NHS Trust | 59 | 2014-06-01 | 2021-04-30 |
| Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration ranibizumab - Exudative Age-related Macular Degeneration | Not applicable | Unknown | Mie University | 50 | 2014-06-01 | 2014-12-31 |
| Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion Ranibizumab - Researcher-Subject Relations | Not applicable | Completed | St. Marianna University School of Medicine | 50 | 2014-03-01 | 2017-08-25 |
| Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion ranibizumab - Macular Edema, Branch Retinal Vein Occlusion | Not applicable | Unknown | Tokyo Medical University | 100 | 2013-12-01 | 2014-06-23 |
| Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration Iray, Lucentis - Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration | Not applicable | Unknown | Oraya Therapeutics, Inc. | 12 | 2012-08-01 | 2012-10-25 |
| Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival Xylocaine 2% Injectable Anesthetic, Proparacaine Hydrochloride 0.5% Drop, Tetravisc 0.5% Gel - Age-related Macular Degeneration, Central Retinal Vein Occlusion | Not applicable | Completed | Retina Vitreous Associates of Florida | 57 | 2012-07-01 | 2014-04-21 |
| Effect of Intravitreal Anti-VEGF on Retinal Vessels Diameter Intravitreal Ranibizumab, Intravitreal bevacizumab - Age Related Macular Degeneration | Not applicable | Unknown | University of Malaya | 30 | 2012-04-01 | 2012-06-22 |
| Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes Ranibizumab - Age Related Macular Degeneration | Not applicable | Completed | McMaster University | 70 | 2012-01-01 | 2016-03-17 |
| Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration Avastin, Lucentis - Exudative Macular Degeneration, Diabetic Macular Edema | Not applicable | Completed | Vitreo-Retinal Associates, Michigan | 16 | 2011-11-01 | 2014-12-17 |
| Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD) Ranibizumab, Ranibizumab Injection - Age-Related Macular Degeneration | Not applicable | Unknown | Russian Academy of Medical Sciences | 300 | 2011-10-01 | 2012-08-31 |
| Treatment of Epiretinal Membranes With Ranibizumab intravitreal ranibizumab - Epiretinal Membrane | Not applicable | Completed | Queen's University | 11 | 2010-11-01 | 2016-01-13 |
| An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) Ranibizumab 0.5 mg - Macular Edema, Retinal Vein Occlusion | Not applicable | Completed | Genentech, Inc. | 608 | 2008-07-01 | 2012-01-10 |
| Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery Ranibizumab - Glaucoma | Not applicable | Terminated | University of California, San Francisco | 11 | 2008-04-01 | 2022-08-02 |
| Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) Ranibizumab, Laser photocoagulation - Macular Edema | Not applicable | Completed | Klinikum Ludwigshafen | 30 | 2007-11-01 | 2011-07-22 |
| Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy Ranibizumab - Choroidal Neovascularization | Not applicable | Completed | Vision Research Foundation | 40 | 2007-10-01 | 2012-06-28 |
| Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration ranibizumab - Age-related Macular Degeneration | Not applicable | Completed | Prince of Songkla University | 25 | 2007-08-01 | 2011-04-15 |
Showing 20 of 23. Sign in to see all of them.
Macular Degeneration (9) · Macular Edema (4) · Retinal Vein Occlusion (4) · Wet Macular Degeneration (2) · Choroidal Neovascularization (1) · Epiretinal Membrane (1) · Glaucoma (1) · Infant, Premature, Diseases (1) · Pain (1) · Retinopathy of Prematurity (1) · Vision Disorders (1)
Barnes Retina Institute (1) · Beijing Hospital (1) · Genentech, Inc. (1) · King's College Hospital NHS Trust (1) · Klinikum Ludwigshafen (1) · Lahey Clinic (1) · McMaster University (1) · Mie University (1) · Ophthalmica Eye Institute (1) · Oraya Therapeutics, Inc. (1) · Prince of Songkla University (1) · Queen's University (1) · Retina Vitreous Associates of Florida (1) · Russian Academy of Medical Sciences (1) · Sheba Medical Center (1)
United States (5) · China (3) · Canada (2) · Japan (2) · Belgium (1) · Germany (1) · Greece (1) · Israel (1) · Italy (1) · Malaysia (1) · Russia (1) · Thailand (1) · United Kingdom (1)
Ehud Rechtman, MD (1) · Gaurav K. Shah, MD (1) · Hidetaka Noma, MD (1) · Hongping Xia, MD. PhD (1) · Jeffrey Gale, MD (1) · Jeffrey L Marx, M.D. (1) · Jiro Kogo, M.D., Ph. D. (1) · Lars-Olof Hattenbach, MD, Privatdozent (1) · Lin Lu (1) · Louis C. Glazer, MD (1) · Mariya Budzinskaya, MD, PhD (1) · Michael T Trese, MD (1) · Mineo Kondo (1) · Paris G Tranos, PhD (1) · Patama Bhurayanontachai, MD (1)
PMID 17021318, PMID 17021319, PMID 22712537, PMID 25042729, PMID 32560639